Marco Investment Management Portfolio holdings
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
CVS Health
CVS
|
+$4.97M |
| 2 |
Verizon
VZ
|
+$4.75M |
| 3 |
AbbVie
ABBV
|
+$2.1M |
| 4 |
RTX Corp
RTX
|
+$1.18M |
| 5 |
Vanguard Small-Cap Value ETF
VBR
|
+$790K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Broadcom
AVGO
|
+$10.2M |
| 2 |
Apple
AAPL
|
+$6.76M |
| 3 |
UnitedHealth
UNH
|
+$5.93M |
| 4 |
AGN
Allergan plc
AGN
|
+$4.73M |
| 5 |
JPMorgan Chase
JPM
|
+$1.38M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 27.09% |
| 2 | Healthcare | 18.97% |
| 3 | Financials | 10.11% |
| 4 | Consumer Staples | 9.37% |
| 5 | Consumer Discretionary | 8.51% |
Similar funds
Marco Investment Management's Q2 2020 Portfolio in Review
As of Q2 2020, Marco Investment Management held 170 positions worth $546M, up 16% from $472M the previous quarter. Its ten largest holdings account for 33% of the portfolio.
Marco Investment Management withdrew a net $18.2M in Q2 2020, closing 6 positions and reducing 74 holdings. Its most notable exit was Allergan plc, an estimated $4.73M position sold in full.
By sector, the portfolio is most concentrated in Technology at 27% of assets, down from 28% a quarter earlier, followed by Healthcare and Financials.
Against the trend, Marco Investment Management opened a new position in Vanguard Small-Cap Value ETF worth $842K.
- Marco Investment Management's largest Q2 2020 buy was Vanguard Small-Cap Value ETF: 7,874 shares worth $842K.
- Marco Investment Management added most to CVS Health in Q2 2020, an estimated $4.97M increase.
- Marco Investment Management's biggest Q2 2020 reduction was Broadcom, cutting an estimated $10.2M.
- Marco Investment Management fully exited Allergan plc in Q2 2020, selling an estimated $4.73M.
- Marco Investment Management's ten largest holdings make up 33% of its $546M portfolio in Q2 2020.
- Marco Investment Management opened 13 new positions and closed 6 in Q2 2020.
- Marco Investment Management's portfolio value rose 16% quarter-over-quarter to $546M.
Based on Marco Investment Management's 13F filing for Q2 2020, filed 21 Jul 2020.